UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT E. GRADY JOLLY The plaintiff appeals judgment against him in his suit alleging damages resulting from his prolonged use of a medicine. The trial court dismissed the claims brought against ... Texas Lawyer, 3 weeks ago
1 images for "Qualitest Pharmaceuticals"
Pharmacy News posted: 05/28/2014 Two videos on prescription drug abuse recently emerged from local and national organizations to help educate health care professionals and the public on prescription drug abuse. The first video from Genesee County ...Michigan Pharmacists Association, 2 months ago National Association of Boards of Pharmacy and Anti-Diversion Industry Working Group to Partner on Educational Video Individual.com, 2 months ago New Educational Video for Pharmacists Addresses Prescription Drug Abuse 4 Traders, 2 months ago
Drugmaker Endo International said Monday that its subsidiary, Endo Pharmaceuticals has finalized the sale of its branded drug discovery platform to AsanaBioSciences, an independent affiliate of the Amneal Alliance of Companies. The deal includes ...FDA News, 1 month ago Endo International revenues increase $719M to 1% in Q2 2014 News-Medical.Net, 58 minutes ago Endo International earns $21.16-million in Q2 2014 Stockwatch, 4 hours ago Endo Raises Guidance Earnings Whispers, 5 hours ago
Item 1.01. Entry into a Material Definitive Agreement. On June 24, 2014, Generics International (US), Inc. (d/b/a "Qualitest Pharmaceuticals") ("Qualitest"), a subsidiary of the Registrant, entered into an Agreement and Plan of Merger (the "DAVA ...Equities.com, 1 month ago
Endo International said today it will acquire DAVA Pharmaceuticals, in an up-to-$600 million deal that expands the buyer's generics portfolio with marketed, prelaunch, and pipeline compounds. The acquisition gives Endo DAVA's generics portfolio, ...Genetic Engineering News, 1 month ago Endo buys generics maker DAVA for $575M Equities.com, 1 month ago
PR.com 2014-06-16 Greenville, NC, June 16, 2014 --( PR.com )-- Mayne Pharma has appointed Blake Cullen as vice president of business development for its U.S. generic products division. Cullen who holds both a law degree and an MBA will ...BizWire Express, 1 month ago
on your WebpageAdd Widget >Get your members hooked!